Name | Experiment name | Description | Gender | Genome build | Mapping rate | Uniquely mapping rate | Genome coverage | C coverage | Depth | BS-con Rate |
---|---|---|---|---|---|---|---|---|---|---|
Hom_Brain_NAcc_1 | Brain_NAcc_1 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 81.30% | 76.00% | 88.31% | 89.48% | 13.44 | 99.68% |
Hom_Brain_NAcc_11 | Brain_NAcc_11 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 74.60% | 69.60% | 87.70% | 88.18% | 10.47 | 99.66% |
Hom_Brain_NAcc_12 | Brain_NAcc_12 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 75.20% | 70.40% | 87.61% | 88.03% | 10.18 | 99.66% |
Hom_Brain_NAcc_13 | Brain_NAcc_13 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 79.30% | 74.70% | 87.27% | 87.10% | 10.79 | 99.65% |
Hom_Brain_NAcc_14 | Brain_NAcc_14 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 79.00% | 74.40% | 87.37% | 87.54% | 10.97 | 99.66% |
Hom_Brain_NAcc_15 | Brain_NAcc_15 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 82.80% | 78.50% | 87.16% | 86.63% | 12.09 | 99.75% |
Hom_Brain_NAcc_17 | Brain_NAcc_17 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 79.60% | 74.70% | 87.06% | 87.09% | 12.37 | 99.74% |
Hom_Brain_NAcc_18 | Brain_NAcc_18 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 80.40% | 75.30% | 88.04% | 88.79% | 13.30 | 99.75% |
Hom_Brain_NAcc_3 | Brain_NAcc_3 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 75.70% | 70.60% | 88.05% | 88.24% | 10.56 | 99.67% |
Hom_Brain_NAcc_5 | Brain_NAcc_5 | Brain, nucleus accumbens (NAcc), neuropsychiatrics | - | hg38 | 82.70% | 77.60% | 87.86% | 88.85% | 12.87 | 99.66% |